Our previous study showed that human high-grade gliomas increase TELO2 mRNA expression and that overexpression of TELO2 mRNA expression correlates with shorter survival outcomes, supporting the finding that TELO2 is an oncogene in human gliomas [16]. The gene discussed is TELO2; the disease is central nervous system cancer.